Archean Chemical Industries working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,087.74×1,087.74×—614.18×19,286.77×
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
49.27×49.27×56.27×37.61×34.28×
597.14×597.14×—406.67×12,773.78×
539.87×539.87×—245.12×6,547.27×
17.42×11.62×2.11×2.25×3.56×
0.43×0.43×0.47×0.70×0.88×
1.32×1.32×1.09×1.19×1.30×
0.58×0.58×0.56×0.82×0.78×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ACI₹454.40

Archean Chemical Industries Ltd.

· Chemicals
₹ CrorePeersNEOGENAETHERALKYLAMINEBALAMINESTECILCHEMELLENGHCLGNFCMcap ₹5,610 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Inventory Days (DIO)19,286.77614.18—1,087.741,087.74
Receivable Days (DSO)34.2837.6156.2749.2749.27
Payable Days (DPO)12,773.78406.67—597.14597.14
Cash Conversion Cycle (days)6,547.27245.12—539.87539.87
Working Capital Turnover3.562.252.1111.6217.42
Asset Turnover0.880.700.470.430.43
Cash Conversion (CFO/Net Income)1.301.191.091.321.32
CFO/EBITDA0.780.820.560.580.58
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.